The Kar-Jenner sisters, particularlyKim Kardashian, Khloe, and Kylie, have long faced accusations of using Ozempic, a drug originally for diabetes that gained prominence as a weight-loss aid in 2022. Now, Kourtney Kardashian Barker's supplement brand, Lemme, launched two years ago and valued at £2.4 billion, is at the center of a new controversy for releasing an "Ozempic-style" weight-loss supplement, capitalizing on the drug's popularity.

Last week, Lemme announced its latest product, named GLP-1 Daily, a direct reference to the GLP-1 hormone. Ozempic is a weekly injection containing a synthetic version of this hormone, which naturally slows digestion, dulls hunger, and aids in weight loss. While Lemme's GLP-1 Daily is marketed to "reduce body weight, visceral fat, and hip and waist circumference," it does not contain the key synthetic ingredients found in Ozempic. Instead, it claims to naturally increase GLP-1 levels over time using lemon and saffron extracts. Although Kourtney hasn't explicitly compared her product to Ozempic, she did promote an article discussing her desire to be "in on the Ozempic boom," and a brand email described it as "a GLP-1 solution without the side effects" of Ozempic.

Photo Credit: Page Six Style

This new supplement has drawn significant criticism from fans and medical professionals alike. Many have slammed Kourtney, who previously advocated for body positivity, for seemingly exploiting insecurities. Critics on social media labeled it a "facade" and "false marketing," asserting that oral supplements cannot mimic GLP-1 medications for weight loss due to rapid enzymatic breakdown. Plastic surgeon Naveen Cavale, from Real Plastic Surgery, expressed strong disapproval, calling the product "incredibly misleading" and a "cash grab" that preys on young women struggling with body image, potentially exacerbating mental health issues like anxiety, stress, and depression. He emphasized that the supplement lacks the scientifically proven impact of injectable medications like Ozempic, which contains semaglutide, a rigorously tested GLP-1 receptor.

Cavale further explained that if Lemme's pill truly contained GLP-1, it would be classified as a drug, not a supplement. He stated there is "little to no clinical evidence to support significant weight loss from these ingredients." A critical point of contention is Lemme's small print disclaimer: "This product is not intended to diagnose, treat, cure or prevent any disease." This highlights that the claims have not been evaluated by the Food and Drug Administration (FDA), which ensures the safety, efficacy, and security of drugs and approved supplements.

Photo Credit: Daily Mail

This isn't Lemme's first brush with controversy. In June, Kourtney launched Lemme Smooth capsules, claiming they could reduce cellulite in just 28 days using French Cantaloupe Melon extract. Medical experts, including Naveen Cavale, dismissed this as a "fad" and an "ineffective solution" for a perfectly normal skin condition, emphasizing that cellulite is natural and anti-cellulite pills lack scientific backing. Again, the product carried the same FDA disclaimer. Prior to that, in February last year, Lemme released "Lemme Purr" vagina gummies, marketed to boost vaginal health and alter its taste with pineapple, Vitamin C, and probiotics. Gynaecologist Dr. Jen Gunter vehemently criticized this, calling anyone who suggests a vagina needs improved freshness or taste "a misogynist and awful person," and labeling the product a "grift."

Kourtney Kardashian has historically been known as the most health-conscious sister in her family, adhering to strict diets and promoting wellness since the birth of her eldest son, Mason, in 2009. She launched Lemme in September 2022 with the aim of creating "science-backed" vitamins and supplements. However, despite her wellness image, the brand continues to face significant backlash for products that experts claim lack scientific evidence, exploit consumer insecurities, and are potentially misleading, prompting ongoing calls for greater transparency and adherence to proven health solutions.